Almonty Faces a Two-Front Test as Tungsten Prices Slide and Sangdong Timelines Slip

A buy rating is not a safety net. For Almonty, that lesson now arrives from two directions at once: a tungsten market in broad retreat and a pair of analysts who like the story but have trimmed what they think the shares are worth.

The commodity backdrop has shifted sharply. According to media reports, the Chinese price for the tungsten intermediate APT stood at 470,000 yuan per tonne on October 15 — roughly 69% below its mid-March high. The report described a wide correction across tungsten prices. That matters because operational progress at Sangdong and a supportive price environment are two different things, and an investment case built mainly on individual delivery milestones misses half the picture.

Two Houses, One Direction

On Tuesday, B. Riley Securities cut its price target on Almonty to US$20 from US$25 while keeping its buy recommendation. Stifel had done much the same about two weeks earlier, holding its buy call but reducing its target to US$21 from US$25. Stifel's rationale was revised assumptions about the shipping timing of Sangdong's first and second expansion phases following the company's investor day.

The pairing deserves more attention than the positive verdict alone. A buy recommendation is not a fixed seal of approval on valuation, and reading only the endorsement while ignoring the lowered target — or only the cut while omitting the continued buy — tells just half the story. Analyst Nick Giles likewise maintained his buy rating, so the pattern across the coverage is consistent: conviction intact, expectations recalibrated.

What the Investor Day Actually Said

At that investor day, management stated that Sangdong is in operation and ramping up. Shipments were being prepared, and the company also discussed the second expansion phase. Those are statements of progress — not the same thing as proof of completed deliveries. Analysts responded by pushing their delivery assumptions further out, which turned the timing question into a concrete valuation factor rather than a footnote.

Media reports also indicate Almonty is weighing an additional listing in South Korea, possibly via Korean depositary receipts. That is a capital-markets question, not an operational one. A potential second exchange and the Sangdong ramp-up answer different questions, and conflating the two would be a mistake.

Reading the Tape Without Overreading It

The stock's daily moves offer no verdict on any of this. A decline of 3.6% on one day and 5.1% on another fit the more cautious mood, but neither proves an additional operational setback nor an immediate link to any single analyst decision. Share-price swings cannot tell you whether the ramp-up is succeeding or the company's plans are failing.

The balanced read, then, is this: the positive analyst ratings argue against a blanket negative interpretation, while the lower targets argue against uncritical confidence. What would tip the scales toward a more convincing valuation is durable operational progress — weighted more heavily than fresh listing ambitions. That is the yardstick against which Almonty's next updates should be judged, with the tungsten price, the delivery schedule and the valuation all considered together rather than in isolation.